COVID-19 Testing for the Essential Workforce
Learn about our efforts to test people on the front line and how you can help.
In fact, recent research has shown that the KRAS-variant plays an important role in the body’s response to cancer therapies by affecting an individual’s immune system.
Specifically, studies have found that certain cancer medications are far more effective for KRAS-variant cancer patients, while others work poorly. The difference in taking the wrong versus the right cancer medicine if you are a KRAS-variant patient can lead to up to a 3-fold (300%) difference in your chance of survival. Research to determine which treatments work best for KRAS-variant patients have been conducted in breast,1 ovarian,2,3 colon,4-17 lung,18,19 and head and neck cancer.21-23 To read findings about specific types of cancers, please go here.
If you have been diagnosed with cancer and are making decisions for which type of treatment, you are eligible for our studies as well as KRAS-variant testing. If you would like to join a study, please follow this link. You will be able to get your KRAS-variant results at a discounted cost ($195) through the study. If you would prefer to directly order KRAS-variant testing at cost ($295) without joining a study, please follow this link.
MiraKind’s research is focused on better understanding the lifestyle and environmental factors that impact cancer risk for KRAS-variant individuals so that they may make informed decisions to protect their health. Learn more about MiraKind’s open or future research studies that may be relevant to you.
We encourage you to enroll in a MiraKind study to help us better understand which medicines work best for KRAS-variant individuals who have been diagnosed with cancer. Being a study participant is FREE, and you can choose to get your KRAS-variant results at a discounted price of $195.
We need your help to let people know about the KRAS-variant.